← All Sponsors
SPONSOR

Abramson Cancer Center at Penn Medicine

Total Trials
4
Recruiting
4
Phases
Phase 2, EARLY_Phase 1
Conditions studied: Artifical InteligenceCardiologyBreast CancerSepsisUterine CancerAutoimmunityCancerImmunotoxicityOncologyEndometrial Cancer
NCT06694181
Recruiting

Safe and Explainable AI

Artifical Inteligence
United States View Trial →
NCT05916196 Phase 2
Recruiting

[18F]FES PET/.CT in Uterine Cancer

Uterine Cancer
United States View Trial →
NCT04119713
Recruiting

Autoimmunity After Checkpoint Blockade

Autoimmunity
United States View Trial →
NCT07278986 EARLY_Phase 1
Recruiting

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

Endometrial Cancer
United States View Trial →